Use of Xanomeline/Trospium in Clinical Practice

Panelists discuss how clinicians are beginning to integrate xanomeline/trospium into practice for patients who have struggled with traditional therapies. They share early observations of improved engagement and cognitive clarity.

Panelists discuss how appropriate patient selection, titration, and adverse effect monitoring are key to maximizing outcomes.

Panelists discuss how broad adoption depends on payer coverage and growing real-world data validating long-term safety and effectiveness.